Investor relations

Navamedic ASA aims to generate shareholder value by becoming an international pharmaceutical company.NAVA

The Navamedic ASA shares have since March 31, 2006 been listed  under the NAVA ticker on Oslo Børs (Oslo Stock Exchange).  

Navamedic recognises good corporate governance as an important element in the group's corporate culture and the Board of Directors has adopted a Code of Conduct to be followed by all company personnel. The company aims to maintain good and open communication in order to encourage confidence in the group's activities.

To view share quotes and messages please click on the Navamedic share
and Oslo Børs under the NAVA ticker.

To view all stock exchange releases form the Company, please view Oslo Børs NewsWeb 
under the NAVA ticker.

For further Investor Relation information and/or inquires, please contact;

Björn Lindholt, CFO
Phone +47 671 125 40
Mobile + 47 930 066 01
E-post: bjorn [dot] lindholt [at] navamedic [dot] com 


Håkan Josephsson, Acting CEO
Phone +46 31 335 11 93
Mobile +46 70 674 25 33
Fax + 46 31 335 11 99
E-post:  hakan [dot] josephsson [at] navamedic [dot] com